USP Ephedra Review Scheduled For July; RAND Report Slated For Early Fall
This article was originally published in The Tan Sheet
Executive Summary
The U.S. Pharmacopeia will discuss standard-setting issues related to the supplement ingredient ephedra during an internal meeting July 17